Diagnosis and treatment of cholangiocarcinoma - PubMed (original) (raw)
Review
Diagnosis and treatment of cholangiocarcinoma
Christopher D Anderson et al. Oncologist. 2004.
Free article
Erratum in
- Oncologist. 2004;9(5):598
Abstract
Cholangiocarcinoma presents a formidable diagnostic and treatment challenge. The majority of patients present with unresectable disease and have a survival of less than 12 months following diagnosis. Progress has been made by the appropriate selection of patients for treatment options including resection, with the routine use of more aggressive resections in order to achieve margin-negative resections. This has resulted in longer survival times for these patients. Neoadjuvant and adjuvant therapies have, for the most part, not improved survival in patients with this tumor, and new strategies are needed to improve this line of therapy. The prognosis for unresectable patients is poor, and palliative measures should be aimed at increasing quality of life first and increasing survival second.
Similar articles
- Diagnosis and treatment update: cholangiocarcinoma.
Wijaya I, Abdullah M. Wijaya I, et al. Acta Med Indones. 2011 Jul;43(3):212-5. Acta Med Indones. 2011. PMID: 21979289 - Therapeutic approach to the malignant tumors of the biliary tract.
Mihalache F, Tantău M, Iancu C, Bodea R, Părău A, Acalovschi M. Mihalache F, et al. Rom J Intern Med. 2010;48(2):131-40. Rom J Intern Med. 2010. PMID: 21428177 Review. - Liver transplantation for hepatic and biliary malignancy.
Wall WJ. Wall WJ. Semin Liver Dis. 2000;20(4):425-36. doi: 10.1055/s-2000-13154. Semin Liver Dis. 2000. PMID: 11200413 Review. - The multidisciplinary management of gastrointestinal cancer. Biliary tract cancers: from pathogenesis to endoscopic treatment.
Demols A, Maréchal R, Devière J, Van Laethem JL. Demols A, et al. Best Pract Res Clin Gastroenterol. 2007;21(6):1015-29. doi: 10.1016/j.bpg.2007.09.005. Best Pract Res Clin Gastroenterol. 2007. PMID: 18070701 Review. - Pathology: Does nodal micrometastasis impact outcome in biliary cancer?
Silva MA, Friend PJ. Silva MA, et al. Nat Rev Clin Oncol. 2010 Dec;7(12):680-1. doi: 10.1038/nrclinonc.2010.184. Nat Rev Clin Oncol. 2010. PMID: 21116239 No abstract available.
Cited by
- Prognostic factors in patients with intrahepatic cholangiocarcinoma.
Chang YJ, Chang YJ, Chen LJ. Chang YJ, et al. Sci Rep. 2024 Aug 17;14(1):19084. doi: 10.1038/s41598-024-70124-z. Sci Rep. 2024. PMID: 39154139 Free PMC article. - Failure patterns after curative resection for intrahepatic cholangiocarcinoma: possible implications for postoperative radiotherapy.
Yu W, Hu C, Shui Y, Wu K, Zhang L, Chen Y, Li C, Xu J, Wei Q. Yu W, et al. BMC Cancer. 2019 Nov 14;19(1):1108. doi: 10.1186/s12885-019-6328-3. BMC Cancer. 2019. PMID: 31727017 Free PMC article. - Endoscopic treatment options for cholangiocarcinoma.
Hou LA, Van Dam J. Hou LA, et al. Hepat Oncol. 2014 Apr;1(2):229-240. doi: 10.2217/hep.13.16. Epub 2014 Mar 20. Hepat Oncol. 2014. PMID: 30190957 Free PMC article. Review. - Photodynamic therapy in unresectable cholangiocarcinoma: not for the uncommitted.
Talreja JP, Degaetani M, Ellen K, Schmitt T, Gaidhane M, Kahaleh M. Talreja JP, et al. Clin Endosc. 2013 Jul;46(4):390-4. doi: 10.5946/ce.2013.46.4.390. Epub 2013 Jul 31. Clin Endosc. 2013. PMID: 23964337 Free PMC article. - Development of a questionnaire (EORTC module) to measure quality of life in patients with cholangiocarcinoma and gallbladder cancer, the EORTC QLQ-BIL21.
Friend E, Yadegarfar G, Byrne C, Johnson CD, Sezer O, Pucciarelli S, Pereira SP, Chie WC, Banfield A, Ramage JK; EORTC Quality of Life Group. Friend E, et al. Br J Cancer. 2011 Feb 15;104(4):587-92. doi: 10.1038/sj.bjc.6606086. Epub 2011 Jan 25. Br J Cancer. 2011. PMID: 21266979 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources